No profile data available.
Aclaris Therapeutics, Inc. (ACRS) is a healthcare company in the skin treatment pharmaceuticals industry, based in Wayne, United States, with about 69 full-time employees.
It reported revenue of $7.83 million for fiscal year 2025, down 58.2% from fiscal year 2024, and net income of -$64.92 million. Its market capitalization was $563.77 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a clinical-stage biopharmaceutical company, engages in the discovering and developing novel molecule product candidates for immuno-inflammatory diseases in the United States.
Aclaris Therapeutics reported $7.83 million in revenue for fiscal year 2025, down 58.2% from $18.72 million in fiscal year 2024.
$563.77 million as of October 9, 2026.
Listed companies of a similar size in the same industry (skin treatment pharmaceuticals) include Almirall, S.a. (ALMRY), Trevi Therapeutics, Inc. (TRVI), Avalo Therapeutics, Inc. (AVTX), Evolus, Inc. (EOLS).